Lamictal IR Experience Impresses Advisory Committee, Not XR Trial Design
This article was originally published in The Pink Sheet Daily
Executive Summary
Committee members recommend Lamictal XR as a monotherapy for partial seizures, relying on the knowledge that the immediate-release version of the drug works for the indication.